96. クローン病 Crohn disease Clinical trials / Disease details


臨床試験数 : 2,400 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

  
7 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02806206
(ClinicalTrials.gov)
July 201615/6/2016Prucalopride Prior to Small Bowel Capsule EndoscopyThe Effect of Prucalopride on Small Bowel Transit Time in Patients Undergoing Capsule Endoscopy: A Randomized Controlled TrialGastrointestinal Hemorrhage;Crohn Disease;Celiac Disease;Intestinal Diseases;Inflammatory Bowel DiseasesDrug: Prucalopride;Drug: PlaceboUniversity of British ColumbiaNULLNot yet recruiting19 YearsN/ABoth122Phase 4Canada
2JPRN-UMIN000008199
2012/06/0119/06/2012The investigations for improving successful judgment rate with PillCam Patency Capsule and differential diagnosis in Crohn's disease patients with following capsule endoscopy. Crohn's disease, Patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin more than 3 monthsPatients administered with mosapride
Patients administered with no mosapride
Department of Gastroenterology, Graduate School of Medicine, Osaka City UniversityNULLComplete: follow-up complete12years-old85years-oldMale and Female40Not selectedJapan
3NCT01556672
(ClinicalTrials.gov)
April 201215/3/2012Adalimumab-psoriasis and Small Bowel LesionsOpen-label Study on Small Bowel Lesions Suggestive of Crohn's Disease in Patients With Moderate to Severe Plaque Psoriasis Treated With AdalimumabPlaque Psoriasis;Crohn's DiseaseDrug: Adalimumab;Device: Capsule endoscopyInnovaderm Research Inc.Abbott;AbbottCompleted18 Years80 YearsBoth100Phase 4Canada
4NCT01053559
(ClinicalTrials.gov)
January 201019/1/2010Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule EndoscopyOpen Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule EndoscopyCrohn's DiseaseDrug: certolizumab pegolShafran Gastroenterology CenterUCB PharmaCompleted18 Years70 YearsBoth15N/AUnited States
5NCT00245505
(ClinicalTrials.gov)
February 200926/10/2005The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Drug: Crohn's DiseaseThe Effect on Mucosal Healing With Pentasa Sachet 4g in Mild to Moderate Active Small Bowel Crohn´s Disease, Evaluated by Video Capsule Endoscopy After 6 and 12 Weeks Treatment. A Pilot StudyCrohn's DiseaseDrug: Mesalazine (Mesalamine)Ferring PharmaceuticalsNULLTerminated18 Years70 YearsBoth3Phase 3Sweden
6NCT01144156
(ClinicalTrials.gov)
July 200713/6/2010Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule EndoscopySmall Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule EndoscopyCrohn's DiseaseDrug: Treatment with AdalimumabRabin Medical CenterAbbottNot yet recruiting18 YearsN/ABoth30N/AIsrael
7EUCTR2005-002472-15-SE
(EUCTR)
22/09/200523/06/2005The effect on mucosal healing with Pentasa® Sachet 4 g in mild to moderate active small bowel Crohn's disease, evaluated with video capsule endoscopy after 6 and 12 weeks treatment. A pilot study. - N.A.The effect on mucosal healing with Pentasa® Sachet 4 g in mild to moderate active small bowel Crohn's disease, evaluated with video capsule endoscopy after 6 and 12 weeks treatment. A pilot study. - N.A. Mild to moderate active Crohn's disease
MedDRA version: 7.1;Level: PT;Classification code 10011401
Trade Name: Pentasa Sachet 1 g prolonged release granules
Product Name: Pentasa Sachet 1 g
INN or Proposed INN: mesalazine
Other descriptive name: 5-Aminosalicylic acid
Ferring Laegemidler A/SNULLNot RecruitingFemale: yes
Male: yes
10Sweden